Notícias09/08/2022 Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational studySummaryBackgroundLimited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in... Repositório Covid-1909/08/2022 Abertura de envelopes das Chamadas Públicas nº 12/2022 e 13/2022Data: 16/08/2022 Associado em foco 09/08/2022 Os desafios para quem quer se profissionalizar em farmoquímica no BrasilO mercado mostra-se promissor, porém não é uma área muito buscada entre os jovens por falta de incentivo do setor,... Associado em foco08/08/2022 Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studySummaryBackgroundLittle is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This... Repositório Covid-1904/08/2022 Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine developmentAbstractThe spread of coronavirus diseases has resulted in a clarion call to develop potent drugs and vaccines even as... Repositório Covid-1904/08/2022 Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titerSummaryNeutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,... Repositório Covid-19 04/08/2022 InnoPharma ConferenceO InnoPharma Conference tem como missão ser o principal Encontro Regional de Fornecedores da Indústria Farmacêutica, reunir em um mesmo lugar toda... Outras Notícias03/08/2022 Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2AbstractThe unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in... Repositório Covid-1902/08/2022 Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud,1 Mohammad A Ghattas,1,2 Noor Atatreh1,2 Repositório Covid-19 01/08/2022 Informação de qualidade em primeira mão para nossos associadosA ABIFINA alcançou 4 mil patentes incluídas em suas bases de dados de Monitoramento de Pedidos de Patentes (MPPs). Esses... Acontece na ABIFINA29/07/2022 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveysSummaryBackgroundThe Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the... Repositório Covid-1929/07/2022 Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including OmicronAbstractStudying the antibody response to SARS-CoV-2 informs on how the human immune system can respond to antigenic variants as... Repositório Covid-19
09/08/2022 Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational studySummaryBackgroundLimited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in... Repositório Covid-19
09/08/2022 Abertura de envelopes das Chamadas Públicas nº 12/2022 e 13/2022Data: 16/08/2022 Associado em foco
09/08/2022 Os desafios para quem quer se profissionalizar em farmoquímica no BrasilO mercado mostra-se promissor, porém não é uma área muito buscada entre os jovens por falta de incentivo do setor,... Associado em foco
08/08/2022 Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studySummaryBackgroundLittle is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This... Repositório Covid-19
04/08/2022 Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine developmentAbstractThe spread of coronavirus diseases has resulted in a clarion call to develop potent drugs and vaccines even as... Repositório Covid-19
04/08/2022 Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titerSummaryNeutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,... Repositório Covid-19
04/08/2022 InnoPharma ConferenceO InnoPharma Conference tem como missão ser o principal Encontro Regional de Fornecedores da Indústria Farmacêutica, reunir em um mesmo lugar toda... Outras Notícias
03/08/2022 Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2AbstractThe unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in... Repositório Covid-19
02/08/2022 Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud,1 Mohammad A Ghattas,1,2 Noor Atatreh1,2 Repositório Covid-19
01/08/2022 Informação de qualidade em primeira mão para nossos associadosA ABIFINA alcançou 4 mil patentes incluídas em suas bases de dados de Monitoramento de Pedidos de Patentes (MPPs). Esses... Acontece na ABIFINA
29/07/2022 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveysSummaryBackgroundThe Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the... Repositório Covid-19
29/07/2022 Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including OmicronAbstractStudying the antibody response to SARS-CoV-2 informs on how the human immune system can respond to antigenic variants as... Repositório Covid-19
